Why a Patient Growth Fund Is Sticking With Microsoft and Hess Stock (Yahoo! Finance: Company News)

Yahoo! Finance: Company News
Why a Patient Growth Fund Is Sticking With Microsoft and Hess Stock – The BNY Mellon Worldwide Growth fund continues to focus on the patient strategy of renowned investor Fayez Sarofim, who died in May. …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter